Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex

Infection, Genetics and Evolution

Volumn 12, Issue 4, 2012, Pages 695-700

  Rodrigues, Liliana ^a   Machado, Diana ^a   Couto, Isabel ^a,b   Amaral, Leonard ^a,c   Viveiros, Miguel ^a,c  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c Aix Marseille University   (France)

Author keywords

Efflux inhibitors; Efflux pumps; Isoniazid resistance; Mycobacterium bovis; Mycobacterium tuberculosis

Indexed keywords

CHLORPROMAZINE; ISONIAZID; THIORIDAZINE; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; EFFUSION; EFPA GENE; GENE EXPRESSION; GENETIC CODE; MMPL7 GENE; MMR GENE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; P55 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RV1257C GENE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MEMBRANE TRANSPORT PROTEINS; MYCOBACTERIUM TUBERCULOSIS;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84859421891     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.08.009     Document Type: Article

References (30)

1. Amaral L., Martins M., Viveiros M. Phenothiazines as anti-multi-drug resistant tubercular agents. Infect. Disord. Drug Targets 2007, 7:257-265.
2. Bustin S.A., Beaulieu J.F., Huggett J., Jaggi R., Kibenge F.S., Olsvik P.A., Penning L.C., Toegel S. MIQE précis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol. Biol. 2010, 11:74.
3. DeMarco C.E., Cushing L.A., Frempong-Manso E., Seo S.M., Jaravasa T.A.A., Kaatz G.W. Effux-related resistance to norfloxacin, dyes and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 2007, 51:3235-3239.
4. De Rossi E., Aínsa J.A., Riccardi G. Role of mycobacterial efflux transporters in drug resistance. an unresolved question. FEMS Microbiol. Rev. 2006, 30:36-52.
5. De Rossi E., Branzoni M., Cantoni R., Milano A., Riccardi G., Ciferri O. Mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. J. Bacteriol. 1998, 180:6068-6071.
6. Doran J.L., Pang Y., Mdluli K.E., Moran A.J., Victor T.C., Stokes R.W., Mahenthiralingam E., Kreiswirth B.N., Butt J.L., Baron G.S., Treit J.D., Kerr V.J., Van Helden P.D., Roberts M.C., Nano F.E. Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family. Clin. Diagn. Lab. Immunol. 1997, 4:23-32.
7. Dutta N.K., Mehra S., Kaushal D. A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. PLoS ONE 2010, 5:e10069.
8. Gupta A.K., Katoch V.M., Chauhan D.S., Sharma R., Singh M., Venkatesan K., Sharma V.D. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb. Drug Resist. 2010, 16:21-28.
9. Jiang X., Zhang W., Zhang Y., Gao F., Lu C., Zhang X., Wang H. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb. Drug Resist. 2008, 14:7-11.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
11. Louw G.E., Warren R.M., van Pittius N.C., McEvoy C.R., Van Helden P.D., Victor T.C. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 2009, 53:3181-3189.
12. Martins M., Dastidar S.G., Fanning S., Kristiansen J.E., Molnar J., Pagès J.M., Schelz Z., Spengler G., Viveiros M., Amaral L. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int. J. Antimicrob. Agents 2008, 31:198-208.
13. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 2001, 12:215-223.
14. Pasca M.R., Guglierame P., Arcesi F., Bellinzoni M., De Rossi E., Riccardi G. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2004, 48:3175-3178.
15. Pasca M.R., Guglierame P., De Rossi E., Zara F., Riccardi G. MmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 2005, 49:4775-4777.
16. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 1998, 79:3-29.
17. Ramaswamy S.V., Reich R., Dou S.J., Jasperse L., Pan X., Wanger A., Quitugua T., Graviss E.A. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2003, 47:1241-1250.
18. Ramon-Garcia S., Martín C., Thompson C.J., Aínsa J.A. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob. Agents Chemother. 2009, 53:3675-3682.
19. Rodrigues L., Ainsa J.A., Amaral L., Viveiros M. Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. Recent. Pat. Antiinfect. Drug Discov. 2011, 6:118-127.
20. Rodrigues L., Wagner D., Viveiros M., Sampaio D., Couto I., Vavra M., Kern W.V., Amaral L. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J. Antimicrob. Chemother. 2008, 61:1076-1082.
21. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Humana Press, Totowa, NJ. S. Krawetz, S. Misener (Eds.).
22. Siddiqi N., Das R., Pathak N., Banerjee S., Ahmed N., Katoch V.M., Hasnain S.E. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 2004, 32:109-111.
23. Silva P.E., Bigi F., Santangelo M.P., Romano M.I., Martín C., Cataldi A., Aínsa J.A. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2001, 45:800-804.
24. Springer B., Lucke K., Calligaris-Maibach R., Ritter C., Böttger E.C. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter instrumentation. J. Clin. Microbiol. 2009, 47:1773-1780.
25. Vilchèze C., Jacobs W.R. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 2007, 61:35-50.
26. Viveiros M., Leandro C., Amaral L. Mycobacterial efflux pumps and chemotherapeutic implications. Int. J. Antimicrob. Agents 2003, 22:274-278.
27. Viveiros M., Martins A., Paixão L., Rodrigues L., Martins M., Couto I., Fähnrich E., Kern W.V., Amaral L. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int. J. Antimicrob. Agents 2008, 31:458-462.
28. Viveiros M., Portugal I., Bettencourt R., Victor T.C., Jordaan A.M., Leandro C., Ordway D., Amaral L. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002, 46:2804-2810.
29. Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007 2008, World Health Organization (WHO), WHO, Geneva, Switzerland.
30. Global Tuberculosis Control 2010, World Health Organization (WHO), WHO, Geneva, Switzerland.